Four-Year safety check for promising sickle cell drug
NCT ID NCT07401823
Summary
This study aims to understand the long-term safety of a daily medication called pociredir for adults with sickle cell disease. It will follow 50 participants who previously benefited from the drug in an earlier study, monitoring them for up to 4 years. The main goal is to see if the drug remains safe and well-tolerated over this extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.